Literature DB >> 22108716

Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs.

Yuejun Fu1, Na An, Ke Li, Yali Zheng, Aihua Liang.   

Abstract

Development of glioma-specific nanoparticles has been an area of intense research over the past several years. Iron oxide, multifunctional superparamagnetic, and NaYF(4):Yb,rare-earth upconversion nanoparticles, conjugated with chlorotoxin (CTX, a key toxin in scorpion venom which has been shown to bind specifically to glioma cell surface as a specific chloride channel and matrix metalloproteinase-2 blocker), exhibit high affinity for glioma and direct tumor visualization. We review the latest improvements of CTX-modified nanoparticle platforms which might enable development of more effective therapeutic agents in clinical treatment of glioma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108716     DOI: 10.1007/s11060-011-0763-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  56 in total

Review 1.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

2.  Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors under near-infrared irradiation.

Authors:  Xue-Feng Yu; Zhengbo Sun; Min Li; Yang Xiang; Qu-Quan Wang; Fenfen Tang; Yingliang Wu; Zhijian Cao; Wenxin Li
Journal:  Biomaterials       Date:  2010-08-21       Impact factor: 12.479

Review 3.  Chitosan chemistry and pharmaceutical perspectives.

Authors:  M N V Ravi Kumar; R A A Muzzarelli; C Muzzarelli; H Sashiwa; A J Domb
Journal:  Chem Rev       Date:  2004-12       Impact factor: 60.622

Review 4.  Nanotechnology for the biologist.

Authors:  Scott E McNeil
Journal:  J Leukoc Biol       Date:  2005-05-27       Impact factor: 4.962

5.  Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.

Authors:  Hyon Bin Na; Jung Hee Lee; Kwangjin An; Yong Il Park; Mihyun Park; In Su Lee; Do-Hyun Nam; Sung Tae Kim; Seung-Hoon Kim; Sang-Wook Kim; Keun-Ho Lim; Ki-Soo Kim; Sun-Ok Kim; Taeghwan Hyeon
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

6.  Molecular imaging in cancer.

Authors:  Ralph Weissleder
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

7.  Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.

Authors:  Conroy Sun; Chen Fang; Zachary Stephen; Omid Veiseh; Stacey Hansen; Donghoon Lee; Richard G Ellenbogen; Jim Olson; Miqin Zhang
Journal:  Nanomedicine (Lond)       Date:  2008-08       Impact factor: 5.307

Review 8.  Poly(ethylenimine) and its role in gene delivery.

Authors:  W T Godbey; K K Wu; A G Mikos
Journal:  J Control Release       Date:  1999-08-05       Impact factor: 9.776

9.  Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal.

Authors:  Hyejung Mok; Ji Won Park; Tae Gwan Park
Journal:  Bioconjug Chem       Date:  2008-03-26       Impact factor: 4.774

10.  Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.

Authors:  Jean-Luc Bridot; Anne-Charlotte Faure; Sophie Laurent; Charlotte Rivière; Claire Billotey; Bassem Hiba; Marc Janier; Véronique Josserand; Jean-Luc Coll; Luce Vander Elst; Robert Muller; Stéphane Roux; Pascal Perriat; Olivier Tillement
Journal:  J Am Chem Soc       Date:  2007-03-31       Impact factor: 15.419

View more
  9 in total

1.  Chlorotoxin-conjugated onconase as a potential anti-glioma drug.

Authors:  Xiaomin Wang; Zhanyun Guo
Journal:  Oncol Lett       Date:  2014-12-29       Impact factor: 2.967

Review 2.  Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion.

Authors:  Lucie Dardevet; Dipti Rani; Tarek Abd El Aziz; Ingrid Bazin; Jean-Marc Sabatier; Mahmoud Fadl; Elisabeth Brambilla; Michel De Waard
Journal:  Toxins (Basel)       Date:  2015-03-27       Impact factor: 4.546

Review 3.  Antitumoral activity of snake venom proteins: new trends in cancer therapy.

Authors:  Leonardo A Calderon; Juliana C Sobrinho; Kayena D Zaqueo; Andrea A de Moura; Amy N Grabner; Maurício V Mazzi; Silvana Marcussi; Auro Nomizo; Carla F C Fernandes; Juliana P Zuliani; Bruna M A Carvalho; Saulo L da Silva; Rodrigo G Stábeli; Andreimar M Soares
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

4.  Cytotoxic activity of NN-32 toxin from Indian spectacled cobra venom on human breast cancer cell lines.

Authors:  Saurabh S Attarde; Sangeeta V Pandit
Journal:  BMC Complement Altern Med       Date:  2017-11-28       Impact factor: 3.659

Review 5.  Scorpion venom components as potential candidates for drug development.

Authors:  Ernesto Ortiz; Georgina B Gurrola; Elisabeth Ferroni Schwartz; Lourival D Possani
Journal:  Toxicon       Date:  2014-11-26       Impact factor: 3.033

Review 6.  Current Biochemical Applications and Future Prospects of Chlorotoxin in Cancer Diagnostics and Therapeutics.

Authors:  Sbonelo Khanyile; Priscilla Masamba; Babatunji Emmanuel Oyinloye; Londiwe Simphiwe Mbatha; Abidemi Paul Kappo
Journal:  Adv Pharm Bull       Date:  2019-10-24

7.  Inhibition of epidermal growth factor signaling by the cardiac glycoside ouabain in medulloblastoma.

Authors:  Daniel Wolle; Seung Joon Lee; Zhiqin Li; Alisa Litan; Sonali P Barwe; Sigrid A Langhans
Journal:  Cancer Med       Date:  2014-07-23       Impact factor: 4.452

Review 8.  Chlorotoxin-A Multimodal Imaging Platform for Targeting Glioma Tumors.

Authors:  Gadi Cohen; Scott R Burks; Joseph A Frank
Journal:  Toxins (Basel)       Date:  2018-11-26       Impact factor: 4.546

Review 9.  Bee Venom Components as Therapeutic Tools against Prostate Cancer.

Authors:  Jasmin Katrin Badawi
Journal:  Toxins (Basel)       Date:  2021-05-07       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.